Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions : Where Do we Stand with Chemotherapyinduced Cardiotoxicity?


Journal

Current heart failure reports
ISSN: 1546-9549
Titre abrégé: Curr Heart Fail Rep
Pays: United States
ID NLM: 101196487

Informations de publication

Date de publication:
12 2020
Historique:
accepted: 08 09 2020
pubmed: 24 9 2020
medline: 1 6 2021
entrez: 23 9 2020
Statut: ppublish

Résumé

In the last decade, cardio-oncology has become a discipline on its own, with tremendous research going on to unravel the mechanisms underpinning different manifestations of cardiotoxicity caused by anticancer drugs. Although this domain is much broader than the effect of chemotherapy alone, a lot of questions about anthracycline-induced cardiotoxicity remain unknown. In this invited review, we provide insights in molecular mechanisms behind anthracycline-induced cardiotoxicity and put it in a clinical framework emphasizing the need for patients to understand, detect, and treat this detrimental condition.

Identifiants

pubmed: 32964378
doi: 10.1007/s11897-020-00489-5
pii: 10.1007/s11897-020-00489-5
pmc: PMC7683464
doi:

Substances chimiques

Anthracyclines 0
Antineoplastic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-364

Références

Sci Rep. 2016 May 04;6:25333
pubmed: 27142468
Lab Anim Res. 2017 Jun;33(2):165-170
pubmed: 28747983
Anticancer Drugs. 2005 Aug;16(7):691-707
pubmed: 16027517
Biomed Res Int. 2015;2015:465342
pubmed: 26788502
J Assoc Physicians India. 2004 Oct;52:794-804
pubmed: 15909857
PLoS One. 2017 Nov 13;12(11):e0188025
pubmed: 29131861
Oxid Med Cell Longev. 2015;2015:795602
pubmed: 26491536
N Engl J Med. 1988 Sep 22;319(12):745-52
pubmed: 3137469
Biol Pharm Bull. 2010;33(10):1666-72
pubmed: 20930373
Jpn J Pharmacol. 1998 Apr;76(4):405-13
pubmed: 9623719
Cancer. 1973 Aug;32(2):302-14
pubmed: 4353012
J Clin Oncol. 2005 May 1;23(13):2900-2
pubmed: 15860848
J Am Heart Assoc. 2020 Jan 21;9(2):e015890
pubmed: 31959029
J Pharmacol Exp Ther. 2006 Nov;319(2):934-40
pubmed: 16926266
JACC Cardiovasc Imaging. 2018 Aug;11(8):1122-1131
pubmed: 30092969
In Vivo. 2016 May-Jun;30(3):279-90
pubmed: 27107087
Ann Intern Med. 1996 Jul 1;125(1):47-58
pubmed: 8644988
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Pharmacol Rep. 2009 Jan-Feb;61(1):154-71
pubmed: 19307704
Oxid Med Cell Longev. 2019 Dec 3;2019:9474823
pubmed: 31885826
Nat Med. 2012 Nov;18(11):1639-42
pubmed: 23104132
Eur J Pharmacol. 2019 Sep 15;859:172490
pubmed: 31229536
Oncologist. 2017 Apr;22(4):422-431
pubmed: 28275118
Circulation. 2006 Dec 5;114(23):2474-81
pubmed: 17101852
Eur J Clin Invest. 2016 Mar;46(3):264-84
pubmed: 26728634
N Engl J Med. 2013 Mar 21;368(12):1154-6
pubmed: 23514294
J Pharmacol Exp Ther. 2011 Dec;339(3):807-14
pubmed: 21934029
Int J Mol Med. 2018 Jul;42(1):674-684
pubmed: 29693137
Clin Pharmacokinet. 1994 Jun;26(6):428-38
pubmed: 8070217
Antioxid Redox Signal. 2020 May 20;32(15):1098-1114
pubmed: 31989842
Eur Heart J. 2019 Jun 7;40(22):1756-1763
pubmed: 30085070
Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2468-78
pubmed: 25283819
Biochemistry. 1997 Sep 23;36(38):11293-7
pubmed: 9333325
J Biochem Mol Biol. 2006 Nov 30;39(6):759-65
pubmed: 17129413
Curr Opin Cardiol. 2019 May;34(3):282
pubmed: 30893128
Heart. 2018 Jun;104(12):971-977
pubmed: 29217634
Cancer Manag Res. 2014 Sep 15;6:357-63
pubmed: 25246808
Sci Rep. 2019 Jul 8;9(1):9850
pubmed: 31285514
Arch Immunol Ther Exp (Warsz). 2009 Nov-Dec;57(6):435-45
pubmed: 19866340
Tex Heart Inst J. 2012;39(2):190-8
pubmed: 22740730
Mol Pharmacol. 2003 Feb;63(2):368-77
pubmed: 12527808
Eur Heart J. 2019 Dec 21;40(48):3898-3900
pubmed: 31761931
Biomed Res Int. 2016;2016:9583268
pubmed: 28101515
Med Sci Monit. 2019 Oct 22;25:7898-7907
pubmed: 31636246
Curr Cardiol Rev. 2011 Nov;7(4):214-20
pubmed: 22758622
Sci Rep. 2017 Mar 16;7:44735
pubmed: 28300219
Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1063-93
pubmed: 25239940
Semin Oncol. 2019 Dec;46(6):421-425
pubmed: 31767270
Biomed Res Int. 2014;2014:240642
pubmed: 24701565
Ann Transl Med. 2017 Aug;5(16):324
pubmed: 28861421
Tex Heart Inst J. 2012;39(3):424-7
pubmed: 22719160
Acta Pharm Sin B. 2019 Jul;9(4):690-701
pubmed: 31384530
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
Pediatr Res. 2008 Nov;64(5):488-94
pubmed: 18614963
Cancer Res. 2007 Sep 15;67(18):8839-46
pubmed: 17875725
PLoS One. 2017 Feb 28;12(2):e0172803
pubmed: 28245258
Nat Cancer. 2020 Mar;1(3):315-328
pubmed: 32776015
Cell Death Discov. 2019 Jun 12;5:102
pubmed: 31231550
Mol Carcinog. 2019 Jun;58(6):1033-1045
pubmed: 30737960
ESC Heart Fail. 2019 Dec;6(6):1140-1148
pubmed: 31884717
PLoS One. 2019 Sep 12;14(9):e0221940
pubmed: 31513610
Cell Death Differ. 2020 Feb;27(2):540-555
pubmed: 31209361
Eur J Heart Fail. 2017 Jan;19(1):9-42
pubmed: 27565769

Auteurs

Emma Louise Robinson (EL)

Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, 6229, Maastricht, The Netherlands.

Maral Azodi (M)

Luxembourg Centre for Systems Biomedicine, Université du Luxembourg, 6 Avenue du Swing, L-4367, Belvaux, Luxembourg.

Stephane Heymans (S)

Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, 6229, Maastricht, The Netherlands.

Ward Heggermont (W)

Cardiovascular Research Institute Maastricht, Maastricht University, Universiteitssingel 50, 6229, Maastricht, The Netherlands. w.heggermont@maastrichtuniversity.nl.
Cardiovascular Centre Aalst, OLV Hospital Aalst, Moorselbaan 164, 9300, Aalst, Belgium. w.heggermont@maastrichtuniversity.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH